A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer.

Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...

Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

Supported by positive data from Phase 2b FASCINATE-2 trial of denifanstat in patients with MASH Preparations are ongoing to ...

Hepatocellular carcinoma (HCC) represents a significant global health burden as one of the most common malignancies in individuals with chronic liver disease or cirrhosis. This malignancy evolves ...

July 25, 2024 — A new study brings researchers closer to better understanding the pathology of the fatty liver disease MASH, which stands for metabolic dysfunction-associated steatohepatitis.

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic ... PPAR agonists, such as pioglitazone and ...

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis ...

The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...